Huijun Yuan

Prof. Dr. Huijun Yuan

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2024 in Journal of Genetics and Genomics
Verified
Journal Article
Open access
MWMengge Wang
Mengge Wang
HCHongyu Chen
Hongyu Chen
LLLintao Luo
Lintao Luo
YHYuguo Huang
Yuguo Huang
SDShuhan Duan
Shuhan Duan
GHGuanglin He
Guanglin He
Genetic genealogy provides crucial insights into the complex biological relationships within contemporary and ancient human populations by analyzing shared alleles and chromosomal segments that are identical by descent, to understand kinship, migration patterns, and population dynamics. Within forensic science, forensic investigative genetic genealogy (FIGG) has gained prominence by leveraging next-generation sequencing technologies and population-specific genomic resources, opening new investigative avenues. In this review, we synthesize current knowledge, underscore recent advancements, and discuss the growing role of FIGG in forensic genomics. FIGG has been pivotal in revitalizing dormant inquiries and offering new genetic leads in numerous cold cases. Its effectiveness relies on the extensive SNP profiles contributed by individuals from diverse populations to specialized genomic databases. Advances in computational genomics and the growth of human genomic databases have spurred a profound shift in the application of genetic genealogy across forensics, anthropology, and ancient DNA studies. As the field progresses, FIGG is evolving from a nascent practice into a more sophisticated and specialized discipline, shaping the future of forensic investigations.

12 October 2020 in Aging
Verified
Journal Article
Open access
FQFuping Qian
Fuping Qian
XWXin Wang
Xin Wang
ZYZhenhua Yin
Zhenhua Yin
GXGangcai Xie
Gangcai Xie
HYHuijun Yuan
Huijun Yuan
Renjie ChaiRenjie Chai
Renjie Chai
Hair cells (HCs) function as important sensory receptors that can detect movement in their immediate environment. HCs in the inner ear can sense acoustic signals, while in aquatic vertebrates HCs can also detect movements, vibrations, and pressure gradients in the surrounding water. Many genes are responsible for the development of HCs, and developmental defects in HCs can lead to hearing loss and other sensory dysfunctions. Here, we found that the solute carrier family 4, member 2b (slc4a2b) gene, which is a member of the anion-exchange family, is expressed in the otic vesicles and lateral line neuromasts in developing zebrafish embryos. An in silico analysis showed that the slc4a2b is evolutionarily conserved, and we found that loss of function of slc4a2b resulted in a decreased number of HCs in zebrafish neuromasts due to increased HC apoptosis. Taken together, we conclude that slc4a2b plays a critical role in the development of HCs in zebrafish.

21 January 2025 in Science China Life Sciences
Verified
Journal Article
Closed access
PDF file
LLLintao Luo
Lintao Luo
MWMengge Wang
Mengge Wang
YLYunhui Liu
Yunhui Liu
JLJianbo Li
Jianbo Li
FBFengxiao Bu
Fengxiao Bu
GHGuanglin He
Guanglin He

4 January 2024 in Journal of Genetics and Genomics
Verified
Journal Article
Open access
KWKe Wu
Ke Wu
FBFengxiao Bu
Fengxiao Bu
YWYang Wu
Yang Wu
GZGen Zhang
Gen Zhang
XWXin Wang
Xin Wang
HYHuijun Yuan
Huijun Yuan
Previous studies on genetic diseases predominantly focused on protein-coding variations, overlooking the vast noncoding regions in the human genome. The development of high-throughput sequencing technologies and functional genomics tools has enabled the systematic identification of functional noncoding variants. These variants can impact gene expression, regulation, and chromatin conformation, thereby contributing to disease pathogenesis. Understanding the mechanisms that underlie the impact of noncoding variants on genetic diseases is indispensable for the development of precisely targeted therapies and the implementation of personalized medicine strategies. The intricacies of noncoding regions introduce a multitude of challenges and research opportunities. In this review, we introduce a spectrum of noncoding variants involved in genetic diseases, along with research strategies and advanced technologies for their precise identification and in-depth understanding of the complexity of the noncoding genome. We will delve into the research challenges and propose potential solutions for unraveling the genetic basis of rare and complex diseases.

26 June 2024 in hLife
Verified
Journal Article
Open access
GHGuanglin He
Guanglin He
MWMengge Wang
Mengge Wang
LLLintao Luo
Lintao Luo
QSQiuxia Sun
Qiuxia Sun
HYHaibing Yuan
Haibing Yuan
SXShuhua Xu
Shuhua Xu

17 July 2025 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
QZQian Zhao
Qian Zhao
HPHuifang Peng
Huifang Peng
YMYujin Ma
Yujin Ma
HYHuijun Yuan
Huijun Yuan
HJHongWei Jiang
HongWei Jiang
Adeno-associated virus (AAV), renowned for its exceptionally low pathogenicity and significant efficacy in clinical gene therapy, has emerged as a leading delivery vector in the field of gene therapy. AAV can achieve stable gene expression in various tissues, which has made it a promising treatment for genetic disorders. To date, eight AAV-based gene therapies have been approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA). This review summarizes clinical trials of AAV gene therapies for rare diseases, including ophthalmic diseases, nervous system disorders, hematological diseases, neuromuscular diseases, lysosomal storage diseases. We also explore potential side effects and toxicities associated with AAV therapies. Our objective is to provide valuable insights for researchers and clinicians working on AAV-based therapies, helping improve the safety and effectiveness of these treatments.